MindBio Therapeutics (XCNQ:MBIO) Price-to-Tangible-Book : (As of May. 28, 2024)

View and export this data going back to 2023. Start your Free Trial

What is MindBio Therapeutics Price-to-Tangible-Book?

As of today (2024-05-28), MindBio Therapeutics's share price is C$0.045. MindBio Therapeutics's Tangible Book per Share of Mar. 2024 for the quarter that ended in Mar. 2024 was C$-0.04. Hence, MindBio Therapeutics's Price to Tangible Book Ratio of today is .

The historical rank and industry rank for MindBio Therapeutics's Price-to-Tangible-Book or its related term are showing as below:

XCNQ:MBIO's Price-to-Tangible-Book is not ranked ^*
in the Biotechnology industry.
Industry Median: 2.79
* Ranked among companies with meaningful Price-to-Tangible-Book only.

A closely related ratio is called PB Ratio. As of today, MindBio Therapeutics's share price is C$0.045. MindBio Therapeutics's Book Value per Sharefor the quarter that ended in Mar. 2024 was C$-0.04. Hence, MindBio Therapeutics's P/B Ratio of today is .

MindBio Therapeutics Price-to-Tangible-Book Historical Data

The historical data trend for MindBio Therapeutics's Price-to-Tangible-Book can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

MindBio Therapeutics Price-to-Tangible-Book Chart

MindBio Therapeutics Annual Data

Trend

Jun21

Jun22

Jun23

Price-to-Tangible-Book

MindBio Therapeutics Quarterly Data
	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Price-to-Tangible-Book	Get a 7-Day Free Trial					-	-	-	-	-

Competitive Comparison of MindBio Therapeutics's Price-to-Tangible-Book

For the Biotechnology subindustry, MindBio Therapeutics's Price-to-Tangible-Book, along with its competitors' market caps and Price-to-Tangible-Book data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

MindBio Therapeutics's Price-to-Tangible-Book Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, MindBio Therapeutics's Price-to-Tangible-Book distribution charts can be found below:

* The bar in red indicates where MindBio Therapeutics's Price-to-Tangible-Book falls into.

MindBio Therapeutics Price-to-Tangible-Book Calculation

MindBio Therapeutics's price-to-tangible-book ratio for today is calculated as:

Price to Tangible Book	=	Share Price	/	Tangible Book per Share (Q: Mar. 2024 )
	=	0.045	/	-0.037
	=

It can also be calculated from the numbers for the whole company:

Price to Tangible Book	=	Market Cap	/	Tangible Equity
	=	Market Cap	/	(Total Stockholders Equity	-	Preferred Stock	-	Intangible Assets)

A closely related ratio is called PB Ratio. The difference between Price-to-Tangible-Book Ratio and PB Ratio is that book value other than intangibles are used in the calculation.

Be Aware

Some businesses have very light assets, such as software companies or insurance agencies. The Price-to-Book Ratio does not work well for these companies. Some companies even have negative equity, so the Price-to-Book Ratio cannot be applied to them.

MindBio Therapeutics Price-to-Tangible-Book Related Terms

Thank you for viewing the detailed overview of MindBio Therapeutics's Price-to-Tangible-Book provided by GuruFocus.com. Please click on the following links to see related term pages.

MindBio Therapeutics (XCNQ:MBIO) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » MindBio Therapeutics Corp (XCNQ:MBIO) » Definitions » Price-to-Tangible-Book

Comparable Companies

Traded in Other Exchanges

WF6:Germany

Address

91-97 William Street, Level 4, Melbourne, VIC, AUS, 3000

Website

https://www.mindbiotherapeutics.com

MindBio Therapeutics Corp is pioneering clinical studies into the microdosing of psychedelic medicines to treat a range of medical conditions such as depression, anxiety, PTSD, panic disorder, chronic pain and opiate addictions. Its clinical trials microdosing of psychedelic medicines provide hope for sufferers of mental health conditions with new emerging treatment alternatives. The company invests in clinical research to discover potential new treatment options and aims to create novel medicines and treatment regimes from breakthrough microdosing studies. Geographically, the activities of the company takes place in Australia.